Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSOUZA, Fernando Henrique Carlos de
dc.contributor.authorARAUJO, Daniel Brito de
dc.contributor.authorVILELA, Veronica Silva
dc.contributor.authorBEZERRA, Mailze Campos
dc.contributor.authorSIMOES, Ricardo Santos
dc.contributor.authorBERNARDO, Wanderley Marques
dc.contributor.authorMIOSSI, Renata
dc.contributor.authorCUNHA, Bernardo Matos da
dc.contributor.authorSHINJO, Samuel Katsuyuki
dc.date.accessioned2019-02-21T17:21:11Z
dc.date.available2019-02-21T17:21:11Z
dc.date.issued2019
dc.description.abstractBackground: Recommendations of the Myopathy Committee of the Brazilian Society of Rheumatology for the management and therapy of systemic autoimmune myopathies (SAM). Main body: The review of the literature was done in the search for the Medline (PubMed), Embase and Cochrane databases including studies published until June 2018. The Prisma was used for the systematic review and the articles were evaluated according to the levels of Oxford evidence. Ten recommendations were developed addressing the management and therapy of systemic autoimmune myopathies. Conclusions: Robust data to guide the therapeutic process are scarce. Although not proven effective in controlled clinical trials, glucocorticoid represents first-line drugs in the treatment of SAM. Intravenous immunoglobulin is considered in induction for refractory cases of SAM or when immunosuppressive drugs are contra-indicated. Consideration should be given to the early introduction of immunosuppressive drugs. There is no specific period determined for the suspension of glucocorticoid and immunosuppressive drugs when individually evaluating patients with SAM. A key component for treatment in an early rehabilitation program is the inclusion of strength-building and aerobic exercises, in addition to a rigorous evaluation of these activities for remission of disease and the education of the patient and his/her caregivers.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipBrazilian Society of Rheumatology
dc.identifier.citationADVANCES IN RHEUMATOLOGY, v.59, article ID 6, 12p, 2019
dc.identifier.doi10.1186/s42358-019-0048-x
dc.identifier.issn2523-3106
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30800
dc.language.isoeng
dc.publisherBMCeng
dc.relation.ispartofAdvances in Rheumatology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright BMCeng
dc.subjectDermatomyositiseng
dc.subjectGuidelineseng
dc.subjectPolymyositiseng
dc.subjectSystemic autoimmune myopathieseng
dc.subjectTreatmenteng
dc.subject.otherpneumocystis-carinii-pneumoniaeng
dc.subject.otherinterstitial lung-diseaseeng
dc.subject.otheridiopathic inflammatory myopathieseng
dc.subject.othercell activating factoreng
dc.subject.otherterm-follow-upeng
dc.subject.otherrefractory polymyositiseng
dc.subject.otherjuvenile dermatomyositiseng
dc.subject.othermycophenolate-mofetileng
dc.subject.othermyositis patientseng
dc.subject.othercyclosporine-aeng
dc.subject.wosRheumatologyeng
dc.titleGuidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathieseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalARAUJO, Daniel Brito de:UFP, Pelotas, RS, Brazil
hcfmusp.author.externalVILELA, Veronica Silva:Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil
hcfmusp.author.externalBEZERRA, Mailze Campos:HGF, Fortaleza, Ceara, Brazil
hcfmusp.author.externalCUNHA, Bernardo Matos da:Rede Sarah Hosp Reabilitacao, Brasilia, DF, Brazil
hcfmusp.citation.scopus16
hcfmusp.contributor.author-fmusphcFERNANDO HENRIQUE CARLOS DE SOUZA
hcfmusp.contributor.author-fmusphcRICARDO DOS SANTOS SIMOES
hcfmusp.contributor.author-fmusphcWANDERLEY MARQUES BERNARDO
hcfmusp.contributor.author-fmusphcRENATA MIOSSI
hcfmusp.contributor.author-fmusphcSAMUEL KATSUYUKI SHINJO
hcfmusp.description.articlenumber6
hcfmusp.description.volume59
hcfmusp.origemWOS
hcfmusp.origem.pubmed30670084
hcfmusp.origem.scieloSCIELO:S2523-31062019000100301
hcfmusp.origem.scopus2-s2.0-85060375842
hcfmusp.origem.wosWOS:000457521000003
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAbdul-Aziz R, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0154-4eng
hcfmusp.relation.referenceAggarwal R, 2016, ANN RHEUM DIS, V2017, P792eng
hcfmusp.relation.referenceAggarwal R, 2016, RHEUMATOLOGY, V55, P991, DOI 10.1093/rheumatology/kev444eng
hcfmusp.relation.referenceAlexanderson H, 2014, J RHEUMATOL, V41, P1124, DOI 10.3899/jrheum.131145eng
hcfmusp.relation.referenceAllenbach Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133702eng
hcfmusp.relation.referenceAmato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477eng
hcfmusp.relation.reference[Anonymous], 2009, OXFORD CTR EVIDENCEeng
hcfmusp.relation.reference[Anonymous], 2017, HLTH SURV GUIDeng
hcfmusp.relation.referenceAymonier M, 2017, ANN DERMATOL VENER, V144, P279, DOI 10.1016/j.annder.2016.09.677eng
hcfmusp.relation.referenceBachelez H, 1997, ARCH INTERN MED, V157, P1501, DOI 10.1001/archinte.157.13.1501eng
hcfmusp.relation.referenceBadrising Umesh A, 2017, J Neuromuscul Dis, V4, P327, DOI 10.3233/JND-170234eng
hcfmusp.relation.referenceBertolucci F, 2014, EUR J PHYS REHAB MED, V50, P161eng
hcfmusp.relation.referenceBoehler JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183292eng
hcfmusp.relation.referenceBolosiu HD, 1999, ADV EXP MED BIOL, V455, P349eng
hcfmusp.relation.referenceBronner IM, 2006, ANN RHEUM DIS, V65, P1456, DOI 10.1136/ard.2005.045690eng
hcfmusp.relation.referenceBruhler S, 2015, SWISS MED WEEKLY, V145eng
hcfmusp.relation.referenceBUNCH TW, 1981, ARTHRITIS RHEUM, V24, P45, DOI 10.1002/art.1780240107eng
hcfmusp.relation.referenceBUNCH TW, 1980, ANN INTERN MED, V92, P365, DOI 10.7326/0003-4819-92-3-365eng
hcfmusp.relation.referenceCea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163eng
hcfmusp.relation.referenceChan MJ, 2018, J CLIN PHARM THER, V43, P256, DOI 10.1111/jcpt.12644eng
hcfmusp.relation.referenceChang HK, 2003, J KOREAN MED SCI, V18, P131, DOI 10.3346/jkms.2003.18.1.131eng
hcfmusp.relation.referenceChen F, 2015, INTERN MED J, V45, P641, DOI 10.1111/imj.12754eng
hcfmusp.relation.referenceCherin P, 2002, ARTHRITIS RHEUM, V46, P467, DOI 10.1002/art.10053eng
hcfmusp.relation.referenceCHERIN P, 1994, J RHEUMATOL, V21, P1092eng
hcfmusp.relation.referenceCooper C, 2016, MO J MATH SCI, V28, P1eng
hcfmusp.relation.referenceDagher R, 2012, RHEUMATOL INT, V32, P711, DOI 10.1007/s00296-010-1653-5eng
hcfmusp.relation.referenceDalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225eng
hcfmusp.relation.referenceDalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1eng
hcfmusp.relation.referenceDALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704eng
hcfmusp.relation.referenceDastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974eng
hcfmusp.relation.referenceDavis Joshua S, 2003, Commun Dis Intell Q Rep, V27, P526eng
hcfmusp.relation.referenceDay J, 2017, SEMIN ARTHRITIS RHEU, V46, P642, DOI 10.1016/j.semarthrit.2016.11.001eng
hcfmusp.relation.referenceDe Padilla CML, 2015, CLIN EXP RHEUMATOL, V33, P655eng
hcfmusp.relation.referencede Souza FHC, 2017, CLIN EXP RHEUMATOL, V35, P766eng
hcfmusp.relation.referencede Souza RC, 2017, CLIN EXP RHEUMATOL, V35, P1011eng
hcfmusp.relation.referenceEdge JC, 2006, ARCH DERMATOL, V142, P65, DOI 10.1001/archderm.142.1.65eng
hcfmusp.relation.referenceEnders FB, 2014, ARTHRITIS RHEUMATOL, V66, P2281, DOI 10.1002/art.38676eng
hcfmusp.relation.referenceEnglund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140eng
hcfmusp.relation.referenceESCALANTE A, 1993, J RHEUMATOL, V20, P1340eng
hcfmusp.relation.referenceFathi M, 2012, J INTERN MED, V271, P589, DOI 10.1111/j.1365-2796.2011.02459.xeng
hcfmusp.relation.referenceFeldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1eng
hcfmusp.relation.referenceFrikha F, 2009, RHEUMATOLOGY, V48, P1166, DOI 10.1093/rheumatology/kep147eng
hcfmusp.relation.referenceGerhart JL, 2010, J AM ACAD DERMATOL, V62, P957, DOI 10.1016/j.jaad.2009.07.042eng
hcfmusp.relation.referenceGono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258eng
hcfmusp.relation.referenceGordon PA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003643.pub4eng
hcfmusp.relation.referenceGottfried I, 2000, EUR J DERMATOL, V10, P29eng
hcfmusp.relation.referenceGuissa VR, 2012, CLIN EXP RHEUMATOL, V30, P583eng
hcfmusp.relation.referenceGuyatt GH, 2008, BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AEeng
hcfmusp.relation.referenceGuyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.ADeng
hcfmusp.relation.referenceHICKS JE, 1993, J RHEUMATOL, V20, P1399eng
hcfmusp.relation.referenceHIRANO F, 1993, INTERNAL MED, V32, P749, DOI 10.2169/internalmedicine.32.749eng
hcfmusp.relation.referenceHoa SAT, 2017, SEMIN ARTHRITIS RHEU, V46, P488, DOI 10.1016/j.semarthrit.2016.07.014eng
hcfmusp.relation.referenceHOFFMAN GS, 1983, AM J MED, V75, P433, DOI 10.1016/0002-9343(83)90344-3eng
hcfmusp.relation.referenceIannone F, 2006, J RHEUMATOL, V33, P1802eng
hcfmusp.relation.referenceIberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700eng
hcfmusp.relation.referenceIbrahim F, 2015, RHEUMATOLOGY, V54, P1050, DOI 10.1093/rheumatology/keu442eng
hcfmusp.relation.referenceIshizuka M, 2016, MOD RHEUMATOL, V26, P115, DOI 10.3109/14397595.2015.1054081eng
hcfmusp.relation.referenceJick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705eng
hcfmusp.relation.referenceJOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-Ieng
hcfmusp.relation.referenceKadoya A, 1996, J RHEUMATOL, V23, P1186eng
hcfmusp.relation.referenceKim HA, 1998, CLIN EXP RHEUMATOL, V16, P9eng
hcfmusp.relation.referenceKobayashi N, 2015, J RHEUMATOL, V42, P2412, DOI 10.3899/jrheum.140977eng
hcfmusp.relation.referenceKrystufkova O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405eng
hcfmusp.relation.referenceKubo M, 2000, RHEUMATOLOGY, V39, P632, DOI 10.1093/rheumatology/39.6.632eng
hcfmusp.relation.referenceKuhn MA, 2013, OTOLARYNG CLIN N AM, V46, P1087, DOI 10.1016/j.otc.2013.08.006eng
hcfmusp.relation.referenceLam CS, 2006, EUR J CLIN MICROBIOL, V25, P14, DOI 10.1007/s10096-005-0070-2eng
hcfmusp.relation.referenceLambotte O, 2005, J RHEUMATOL, V32, P1369eng
hcfmusp.relation.referenceLeclair V, 2017, CURR OPIN RHEUMATOL, V29, P652, DOI 10.1097/BOR.0000000000000430eng
hcfmusp.relation.referenceLems WF, 2015, ENDOCRINE, V49, P628, DOI 10.1007/s12020-015-0639-1eng
hcfmusp.relation.referenceLevine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849eng
hcfmusp.relation.referenceLi X, 2006, JCR-J CLIN RHEUMATOL, V12, P114, DOI 10.1097/01.rhu.0000221794.24431.36eng
hcfmusp.relation.referenceLoell I, 2011, J INTERN MED, V269, P243, DOI 10.1111/j.1365-2796.2010.02334.xeng
hcfmusp.relation.referenceLundberg IE, 2017, ARTHRITIS RHEUMATOL, V69, P2271, DOI 10.1002/art.40320eng
hcfmusp.relation.referenceMahler EAM, 2011, RHEUMATOLOGY, V50, P2206, DOI 10.1093/rheumatology/ker088eng
hcfmusp.relation.referenceMajithia V, 2005, RHEUMATOLOGY, V44, P386, DOI 10.1093/rheumatology/keh499eng
hcfmusp.relation.referenceMarie I, 2001, J RHEUMATOL, V28, P2230eng
hcfmusp.relation.referenceMarie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003eng
hcfmusp.relation.referenceMathur T, 2015, AM J THER, V22, P350, DOI 10.1097/MJT.0b013e3182987983eng
hcfmusp.relation.referenceMatsubara S, 1997, J NEUROIMMUNOL, V76, P75, DOI 10.1016/S0165-5728(97)00033-7eng
hcfmusp.relation.referenceMatz EL, 2017, UROLOGY, V100, P16, DOI 10.1016/j.urology.2016.07.030eng
hcfmusp.relation.referenceMcHugh NJ, 2018, NAT REV RHEUMATOL, V14, P290, DOI 10.1038/nrrheum.2018.56eng
hcfmusp.relation.referenceMira-Avendano IC, 2013, RESP MED, V107, P890, DOI 10.1016/j.rmed.2013.02.015eng
hcfmusp.relation.referenceMitsunaka H, 2000, SCAND J RHEUMATOL, V29, P192eng
hcfmusp.relation.referenceMoerman M, 2002, EUR ARCH OTO-RHINO-L, V259, P1, DOI 10.1007/PL00007520eng
hcfmusp.relation.referenceMok CC, 2007, J RHEUMATOL, V34, P1864eng
hcfmusp.relation.referenceMorganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212eng
hcfmusp.relation.referenceMosca M, 2000, CLIN EXP RHEUMATOL, V18, P451eng
hcfmusp.relation.referenceMunters LA, 2016, ARTHRITIS RHEUMATOL, V68, P1738, DOI 10.1002/art.39624eng
hcfmusp.relation.referenceMunters LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4263eng
hcfmusp.relation.referenceMunters LA, 2013, ARTHRIT CARE RES, V65, P1959, DOI 10.1002/acr.22068eng
hcfmusp.relation.referenceMurach KA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12973eng
hcfmusp.relation.referenceNader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016eng
hcfmusp.relation.referenceNader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53eng
hcfmusp.relation.referenceNaji P, 2010, NEUROL INDIA, V58, P58, DOI 10.4103/0028-3886.60398eng
hcfmusp.relation.referenceNakashima Shoko, 2002, Ryumachi, V42, P895eng
hcfmusp.relation.referenceNarazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152eng
hcfmusp.relation.referenceNewman E D, 1995, J Clin Rheumatol, V1, P99, DOI 10.1097/00124743-199504000-00007eng
hcfmusp.relation.referenceNistala K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4311eng
hcfmusp.relation.referenceNoss EH, 2006, J RHEUMATOL, V33, P1021eng
hcfmusp.relation.referenceNozaki K, 2009, J NEUROL NEUROSUR PS, V80, P904, DOI 10.1136/jnnp.2008.161448eng
hcfmusp.relation.referenceNzeusseu A, 1999, CLIN EXP RHEUMATOL, V17, P441eng
hcfmusp.relation.referenceOddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754eng
hcfmusp.relation.referenceOddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291eng
hcfmusp.relation.referenceOddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3eng
hcfmusp.relation.referenceOh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441eng
hcfmusp.relation.referenceOlazagasti JM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0543-yeng
hcfmusp.relation.referenceOlazagasti JM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0075-2eng
hcfmusp.relation.referencePapadopoulou D, 2014, RHEUMATOL INT, V34, P151, DOI 10.1007/s00296-013-2907-9eng
hcfmusp.relation.referencePinhata MM, 2015, CLIN EXP RHEUMATOL, V33, P310eng
hcfmusp.relation.referencePisoni CN, 2007, RHEUMATOLOGY, V46, P516, DOI 10.1093/rheumatology/kel336eng
hcfmusp.relation.referenceQushmaq KA, 2000, J RHEUMATOL, V27, P2855eng
hcfmusp.relation.referenceRaghu P, 2015, AM J THER, V22, P244, DOI 10.1097/MJT.0000000000000175eng
hcfmusp.relation.referenceRavn P, 2004, SCAND J INFECT DIS, V36, P499, DOI 10.1080/00365540410015222eng
hcfmusp.relation.referenceReed AM, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0710-3eng
hcfmusp.relation.referenceReed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659eng
hcfmusp.relation.referenceRider Lisa G., 2003, Journal of Rheumatology, V30, P603eng
hcfmusp.relation.referenceSaito E, 2008, MOD RHEUMATOL, V18, P34, DOI 10.1007/s10165-007-0013-0eng
hcfmusp.relation.referenceSanei-Moghaddam A, 2013, BMJ CASE REP, V2013eng
hcfmusp.relation.referenceSantiago M, 2009, EUR J INTERN MED, V20, P744, DOI 10.1016/j.ejim.2009.09.001eng
hcfmusp.relation.referenceSchiopu E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3704eng
hcfmusp.relation.referenceSchrey A, 2017, J NEUROL SCI, V380, P142, DOI 10.1016/j.jns.2017.07.031eng
hcfmusp.relation.referenceSeshadri R, 2008, ARTHRIT RHEUM-ARTHR, V59, P989, DOI 10.1002/art.23829eng
hcfmusp.relation.referenceShinjo SK, 2015, CLIN EXP RHEUMATOL, V33, P336eng
hcfmusp.relation.referenceShinjo SK, 2012, VACCINE, V31, P202, DOI 10.1016/j.vaccine.2012.10.063eng
hcfmusp.relation.referenceSanchez-Fernandez AS, 2013, REUMATOL CLIN, V9, P117, DOI 10.1016/j.reuma.2012.02.007eng
hcfmusp.relation.referenceStern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3eng
hcfmusp.relation.referenceTiffreau V, 2017, ARCH PHYS MED REHAB, V98, P227, DOI 10.1016/j.apmr.2016.09.125eng
hcfmusp.relation.referenceTjarnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751eng
hcfmusp.relation.referenceUchino M, 2012, EUR NEUROL, V68, P117, DOI 10.1159/000338474eng
hcfmusp.relation.referenceUnger L, 2014, RHEUMATOLOGY, V53, P1630, DOI 10.1093/rheumatology/keu024eng
hcfmusp.relation.referenceUtsunomiya M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1206-8eng
hcfmusp.relation.referencevan Assen S, 2011, AUTOIMMUN REV, V10, P341, DOI 10.1016/j.autrev.2010.12.003eng
hcfmusp.relation.referencevan de Vlekkert J, 2010, NEUROMUSCULAR DISORD, V20, P382, DOI 10.1016/j.nmd.2010.03.011eng
hcfmusp.relation.referencevan der Kooi A J, 2014, Handb Clin Neurol, V119, P495, DOI 10.1016/B978-0-7020-4086-3.00032-1eng
hcfmusp.relation.referenceVarju C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oaeng
hcfmusp.relation.referenceVencovsky J, 2000, SCAND J RHEUMATOL, V29, P95, DOI 10.1080/030097400750001897eng
hcfmusp.relation.referenceVillalba L, 1998, ARTHRITIS RHEUM-US, V41, P392, DOI 10.1002/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-Xeng
hcfmusp.relation.referenceWard MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-Meng
hcfmusp.relation.referenceWendling D, 2007, REV MED INTERNE, V28, P194, DOI 10.1016/j.revmed.2006.12.001eng
hcfmusp.relation.referenceWiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196eng
hcfmusp.relation.referenceWINKELMA.RK, 1968, MAYO CLIN PROC, V43, P545eng
hcfmusp.relation.referenceWolfe RM, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0664-6eng
hcfmusp.relation.referenceYale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5eng
hcfmusp.relation.referenceYao L, 2016, RHEUMATOLOGY, V55, P441, DOI 10.1093/rheumatology/kev344eng
hcfmusp.relation.referenceYu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication4ba63a7c-235d-4b1a-a2ae-81b0d3e7880c
relation.isAuthorOfPublication5caafbee-ceff-4b75-97a8-bd0468ffc9c4
relation.isAuthorOfPublicationc86b438c-c045-42c0-bbbb-347de72d169c
relation.isAuthorOfPublication2833bf0a-6e3b-48a8-bfad-d3fdd3e20fa0
relation.isAuthorOfPublication07f179c5-58d8-4efe-832c-52095a9009d6
relation.isAuthorOfPublication.latestForDiscovery4ba63a7c-235d-4b1a-a2ae-81b0d3e7880c
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SOUZA_Guidelines_of_the_Brazilian_Society_of_Rheumatology_for_2019.PDF
Tamanho:
925.54 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)